scholarly journals P10‐22: The diagnostic role of portable respiratory monitor in heart failure patient with Cheyne Stoke respiration

Respirology ◽  
2021 ◽  
Vol 26 (S3) ◽  
pp. 406-407
Keyword(s):  
Heart Failure ◽  
Heart Failure Patient ◽  
Diagnostic Role

scholarly journals Decision-making in advanced heart failure patients requiring LVAD insertion: Can preoperative simulation become the way forward? A case study

2018 ◽  
Vol 4 (2) ◽  
pp. 8 ◽  
Author(s):  
Capoccia M ◽  
Marconi S ◽  
De Lazzari C
Keyword(s):  
Heart Failure ◽  
Decision Making ◽  
Heart Failure Patient ◽  
Clinical Decision ◽  
Daily Basis ◽  
Advanced Heart Failure ◽  
Patient Specific ◽  
Circulatory Support ◽  
Planning Strategy

Clinical practice heavily relies on results from randomized controlled trials, which may not reflect completely individual patients. Patient-specific modelling has received increasing attention in recent years. Although still far from clinical application on a daily basis, the potential of this approach is significant. The treatment of advanced heart failure may benefit from a modelling framework to guide device treatment and predict outcome. The role of mechanical circulatory support as a long-term solution is increasing in view of the evolving technology and worsening heart failure patient population. Therefore, a preoperative strategy with the ability to predict the course of events in a simulation setting may be justified. Here we present a heart failure patient discussed at a multidisciplinary team meeting whose outcome was compared with simulations carried out with CARDIOSIM$^{©}$ software to investigate the role of this approach as a planning strategy to guide intervention and predict outcome. The clinical decision process is complex and many factors are involved. Patient-specific modelling may have a role to play as part of a preoperative planning strategy with more quantitative evaluation to smooth decision-making.

Brain Natriuretic Peptide: It’s Not About the Brain or Just Another Smart Polypeptide—It’s About the Heart

2015 ◽  
Vol 34 (6) ◽  
pp. 355-360
Author(s):  
Dominick M. Carella
Keyword(s):  
Heart Failure ◽  
Brain Natriuretic Peptide ◽  
Natriuretic Peptide ◽  
Congenital Heart ◽  
Pediatric Patients ◽  
Ductus Arteriosus ◽  
Predictive Biomarker ◽  
Diagnostic Role ◽  
The Brain

AbstractBrain natriuretic peptide (BNP) is a cardiac hormone with diuretic, natriuretic, and vasodilator properties. Measurement of plasma B-type natriuretic peptide concentrations is increasingly used to aid diagnosis, assess prognosis, and tailor treatment in adults with congestive heart failure. Recent studies suggest that the peptide is also useful in pediatric patients. The diagnostic role of plasma BNP in neonates admitted to the NICU has shown promise as an aid in diagnosis in neonates with signs of congenital heart disease; as a biomarker of bronchopulmonary dysplasia, patent ductus arteriosus, and persistent pulmonary hypertension of the newborn; a predictive biomarker of the response to indomethacin in preterm infants; and, more significantly, in acute heart failure.

Role of Palliative Care in the Outpatient Management of the Chronic Heart Failure Patient

2019 ◽  
Vol 16 (6) ◽  
pp. 220-228 ◽  
Author(s):  
Sarah Chuzi ◽  
Esther S. Pak ◽  
Akshay S. Desai ◽  
Kristen G. Schaefer ◽  
Haider J. Warraich
Keyword(s):  
Heart Failure ◽  
Palliative Care ◽  
Chronic Heart Failure ◽  
Heart Failure Patient ◽  
Chronic Heart Failure Patient ◽  
Outpatient Management

Redefinition of diagnostic role of inferior vena cava ultrasonography in the identification of acute heart failure

2014 ◽  
Vol 32 (7) ◽  
pp. 799-800 ◽  
Author(s):  
A. Gianstefani ◽  
F. Savelli ◽  
A. Gramenzi ◽  
E. Zucconi ◽  
N. Di Battista ◽  
...  
Keyword(s):  
Heart Failure ◽  
Inferior Vena Cava ◽  
Acute Heart Failure ◽  
Inferior Vena ◽  
Vena Cava ◽  
Diagnostic Role

Protective role of peroxiredoxin-4 in heart failure

2020 ◽  
Vol 134 (1) ◽  
pp. 71-72
Author(s):  
Naseer Ahmed ◽  
Masooma Naseem ◽  
Javeria Farooq
Keyword(s):  
Heart Failure ◽  
Cardiac Fibroblasts ◽  
Protective Role ◽  
Oxidative Stress Markers ◽  
Stress Markers ◽  
Total Antioxidant ◽  
Galectin 3 ◽  
Consequent Increase ◽  
And Oxidative Stress

Abstract Recently, we have read with great interest the article published by Ibarrola et al. (Clin. Sci. (Lond.) (2018) 132, 1471–1485), which used proteomics and immunodetection methods to show that Galectin-3 (Gal-3) down-regulated the antioxidant peroxiredoxin-4 (Prx-4) in cardiac fibroblasts. Authors concluded that ‘antioxidant activity of Prx-4 had been identified as a protein down-regulated by Gal-3. Moreover, Gal-3 induced a decrease in total antioxidant capacity which resulted in a consequent increase in peroxide levels and oxidative stress markers in cardiac fibroblasts.’ We would like to point out some results stated in the article that need further investigation and more detailed discussion to clarify certain factors involved in the protective role of Prx-4 in heart failure.

Sign in / Sign up

Export Citation Format

Share Document